ArticleJournal of cellular and molecular medicine2023

Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancer.

Yu-Ching Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.